The FDA has approved what could be a breakthrough drug in treating some cancers.
It’s called Vitrakvi.
The drug is designed to fight a specific genetic mutation in some forms of cancer.
It comes in an easy-to-take capsule or in liquid form.
Doctors say some patients, including children, have seen remarkable turnarounds. But they warn it doesn’t work for all cancers and it is expensive if you don’t have insurance.
The wholesale cost for the children’s syrup is $11,000 for a month’s supply and the oral capsules for adults wholesales for $32 per month.
With insurance, most patients would pay $20 or less for a 30 day supply of the medicine.